Diagnostic Utility of Neuregulin for Acute Coronary Syndrome

How Low Can We Go? The High-Sensitivity Cardiac Troponin Debate

(2013) Alan B. Storrow et al.   ANNALS OF EMERGENCY MEDICINE

Third Universal Definition of Myocardial Infarction

(2012) Kristian Thygesen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Outcomes of Hospitalized Patients with Non-Acute Coronary Syndrome and Elevated Cardiac Troponin Level

(2011) Edward O. McFalls et al.   AMERICAN JOURNAL OF MEDICINE

Delta Cardiac Troponin Values in Practice: Are We Ready to Move Absolutely Forward to Clinical Routine?

(2011) F. S. Apple et al.   CLINICAL CHEMISTRY

Circulating neuregulin-1β levels vary according to the angiographic severity of coronary artery disease and ischemia

(2011) Carrie Anna Geisberg et al.   CORONARY ARTERY DISEASE

Implementation of a Sensitive Troponin I Assay and Risk of Recurrent Myocardial Infarction and Death in Patients With Suspected Acute Coronary Syndrome

(2011) Nicholas L. Mills   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Testing of Low-Risk Patients Presenting to the Emergency Department With Chest Pain

(2010) Ezra A. Amsterdam et al.   CIRCULATION

Neuregulin-1β Is Associated With Disease Severity and Adverse Outcomes in Chronic Heart Failure

(2009) Bonnie Ky et al.   CIRCULATION

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

(2009)   LANCET

Evaluation of High-Sensitivity Assays for Cardiac Troponin

(2008) D. A. Morrow et al.   CLINICAL CHEMISTRY